Targeted testing to evaluate over 500 genetic variants including 23 pathogenic variants recommended by the American College of Medical Genetics and Genomics.
Confirmation of a clinical diagnosis of cystic fibrosis
Reproductive risk refinement via carrier screening for individuals in the general population
Reproductive risk refinement via carrier screening for individuals with a family history when familial variants are not available
Identification of patients who may respond to cystic fibrosis transmembrane conductance regulator (CFTR) potentiator therapy
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting
Send whole blood specimen in original tube.
Do NOT aliquot.
Specimen must be received at performing lab within 96 hours of collection.
ACD whole blood
Yellow ACD (A or B)
Ambient (preferred) - 96 hours
Performance
Mayo Clinic Laboratories (CFMP): R-NX
Th, Su
20-42 days
Targeted genotyping array
Clinical and Interpretive info
An interpretive report will be provided
Billing
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.